Calidi Biotherapeutics (CLDI) EBIT (QoQ) (2022 - 2025)
Calidi Biotherapeutics (CLDI) EBIT (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Calidi Biotherapeutics | 1.96 Mn | -2.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.53% |
| Sep 30, 2025 | 10.88% |
| Jun 30, 2025 | -11.89% |
| Mar 31, 2025 | -25.73% |
| Dec 31, 2024 | 22.96% |
| Sep 30, 2024 | 9.46% |
| Jun 30, 2024 | 14.51% |
| Mar 31, 2024 | 31.24% |
| Dec 31, 2023 | -35.99% |
| Sep 30, 2023 | -10.46% |
| Jun 30, 2023 | -20.74% |
| Mar 31, 2023 | -15.49% |
| Dec 31, 2022 | 32.89% |
| Sep 30, 2022 | -1,831.85% |
| Jun 30, 2022 | 31.62% |